跳轉至內容
Merck
  • Haemostatic changes in urogenital schistosomiasis haematobium: a case-control study in Gabonese schoolchildren.

Haemostatic changes in urogenital schistosomiasis haematobium: a case-control study in Gabonese schoolchildren.

Journal of helminthology (2019-09-11)
M M Mebius, A A Adegnika, J F Zinsou, J C D Agobe, Y J Honkpehedji, M Yazdanbakhsh, G J van Dam, P L A M Corstjens, A G M Tielens, P G de Groot, R T Urbanus, J J van Hellemond
摘要

In many tropical areas schistosomiasis is a major health problem causing hepatosplenic, intestinal or urogenital complaints. Hepatosplenic schistosomiasis mansoni is also characterized by blood coagulation abnormalities. Liver pathology plays a role in the development of haemostatic changes and the parasitic infection may directly affect coagulation. However, these contributing factors cannot be studied separately in hepatosplenic schistosomiasis infections. This pilot study provides insight in haemostatic changes in urinary schistosomiasis by studying coagulation parameters in schistosomiasis haematobium-infected Gabonese schoolchildren. Selection on urinary schistosomiasis patients without hepatosplenic complaints allows for the investigation of the direct effects of the parasite on haemostasis. Levels of von Willebrand Factor (VWF) antigen, active VWF and osteoprotegerin were elevated, indicating inflammation-mediated endothelial activation. In contrast to hepatosplenic schistosomiasis, thrombin-antithrombin complex and D-dimer levels were not affected. Despite its small sample size, this study clearly indicates that Schistosoma haematobium directly alters the activation status of the endothelium, without initiation of coagulation.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
人VWF / von Willebrand因子ELISA试剂盒, for serum, plasma, cell culture supernatants and urine